Physiological role and mechanism of action
In the blood coagulation cascade, thrombin (activated factor IIa) is a key enzyme. It is formed from its inactive precursor, prothrombin (factor II).
Prothrombin activation is mediated by the prothrombinase complex, which is formed by a combination of three components:
- activated factor Xa;
- cofactor factor Va;
- calcium ions ($Ca^{2+}$).
This complex acts on prothrombin, converting it into active thrombin. At the final stage of coagulation, thrombin induces partial proteolysis of fibrinogen. As a result of this process, fibrin is formed, the strands of which make up the structural framework of any blood clot.
Formulation and administration
In medical practice, the drug Thrombinum is used exclusively as a topical hemostatic agent.
- Dosage form: ampoules and vials containing at least 125 IU of activity.
- Method of administration: the contents of the vial must be dissolved in 2–50 ml of sterile 0.9% sodium chloride ($NaCl$) solution. The resulting solution is used to irrigate the bleeding surface to quickly stop bleeding.
Pharmacological regulation: thrombin inhibitors
Since thrombin is the main clotting enzyme, it serves as the primary target for anticoagulators. Suppression of its activity in the body can be achieved in two ways: indirectly (via a cofactor) or by direct binding.
1. Antithrombin III-dependent anticoagulants
Endogenous antithrombin III inactivates thrombin (as well as factors Xa, IXa, XIa, XIIa). In the presence of heparin or heparan sulfate (on the surface of the intact endothelium), the rate of this inactivation increases 1000-fold. Drugs of this group affect thrombin differently:
- Standard (unfractionated) heparin: non-selective, inhibits thrombin (IIa) and factor Xa equally (1:1 ratio).
- Low-molecular-weight heparins (LMWHs): (enoxaparin, nadroparin, etc.) predominantly inhibit factor Xa, while their effect on thrombin is significantly weaker (2–4:1 ratio).
- Important: prolonged administration of heparin depletes endogenous antithrombin III reserves. This leads to a drop in the efficacy of thrombin inhibition and requires replacement therapy with antithrombin III concentrates.
Structural features: Activation of antithrombin III requires a unique pentasaccharide sequence. In standard heparin, this is present in only 30% of molecules. The synthetic drug fondaparinux sodium consists solely of this pentasaccharide, but it is highly selective and inhibits only factor Xa, having absolutely no effect on thrombin.
2. Direct thrombin inhibitors
These anticoagulants bind directly to the thrombin molecule without requiring antithrombin III. They are classified according to their mode of binding to the enzyme's sites:
- Bivalent (blocking two sites): bind simultaneously to the catalytic center (responsible for proteolysis) and the substrate-binding site (anion-binding exosite, or exosite 1). This subgroup includes hirudin, desirudin, bivalirudin.
- Univalent (blocking only the catalytic center): synthetic drugs that exclusively block the active center of the enzyme. Representatives: argatroban, dabigatran etexilate.
Briefly: answers to topical questions
Which drugs belong to the group of low-molecular-weight heparins?
The group of low-molecular-weight heparins includes:
- Enoxaparin sodium
- Nadroparin calcium
- Dalteparin sodium
- Reviparin sodium
- Bemiparin sodium
- Parnaparin sodium
What side effects are characteristic of direct thrombin inhibitors?
For dabigatran etexilate, sources indicate the following side effects:
- Hemorrhagic complications — bleeding;
- Possible increase in liver transaminase activity;
- Dyspepsia associated with the irritant effect of tartaric acid in the tablet formulation.
Gastrointestinal bleeding occurs less frequently with dabigatran etexilate than with warfarin.
The prothrombinase complex (Xa + Va + Ca2+) converts prothrombin (II) into THROMBIN (IIa), and thrombin converts fibrinogen into FIBRIN.
Class and exam questions
How is the drug Thrombin administered?
The drug is used topically only. The contents of the vial (from 125 IU) are dissolved in 2–50 ml of 0.9% NaCl solution and used to irrigate the bleeding surface.
How does standard heparin affect thrombin?
Standard heparin works in a complex with antithrombin III and non-selectively inhibits thrombin (factor IIa) and factor Xa in a 1:1 ratio.
What is the difference between direct thrombin inhibitors?
Bivalent drugs (e.g., hirudin) block two sites of the enzyme simultaneously: the catalytic center and the substrate-binding site. Univalent drugs (e.g., dabigatran) block only the catalytic center.
Does fondaparinux sodium act on thrombin?
No. Fondaparinux sodium is a highly selective drug and inhibits exclusively factor Xa, without affecting thrombin (factor IIa).
What else to study on this topic
- The prothrombinase complex and the complete coagulation cascade
- Antithrombin III: physiological role and replacement therapy drugs
- Comparative pharmacokinetics of heparin, LMWH, and fondaparinux
- Direct thrombin inhibitors: mechanism of action of hirudin and dabigatran
- Heparin-induced thrombocytopenia (HIT) and the role of platelet factor 4
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thrombin" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.